The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease

E-ISSN： 1873-4286|19|17|3143-3149

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.17, 2013-05, pp. : 3143-3149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors

By Shinkai H.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 99-106

Informa Healthcare

Access to resources Recommend Favorite

On- and Off-Target Pharmacology of Torcetrapib: Current Understanding and Implications for the Structure Activity Relationships (SAR), Discovery and Development of Cholesteryl Ester-Transfer Protein (CETP) Inhibitors

By Johns Douglas G. Duffy Joseph Fisher Timothy Hubbard Brian K. Forrest Michael J.

Drugs, Vol. 72, Iss. 4, 2012-03 ,pp. : 491-507

Adis International

Access to resources Recommend Favorite

Dalcetrapib, a cholesteryl ester transfer protein modulator

By Hooper Amanda J Burnett John R

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1427-1432

Informa Healthcare

Access to resources Recommend Favorite